Does ATORVASTATIN Cause Malignant neoplasm progression? 85 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 85 reports of Malignant neoplasm progression have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.1% of all adverse event reports for ATORVASTATIN.
85
Reports of Malignant neoplasm progression with ATORVASTATIN
0.1%
of all ATORVASTATIN reports
12
Deaths
25
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ATORVASTATIN?
Of the 85 reports, 12 (14.1%) resulted in death, 25 (29.4%) required hospitalization, and 5 (5.9%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 85 reports have been filed with the FAERS database.
What Other Side Effects Does ATORVASTATIN Cause?
Type 2 diabetes mellitus (7,556)
Myalgia (7,155)
Drug hypersensitivity (3,929)
Drug ineffective (3,865)
Fatigue (3,439)
Arthralgia (3,338)
Rhabdomyolysis (3,286)
Dyspnoea (3,137)
Nausea (2,888)
Asthenia (2,791)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ATORVASTATIN Alternatives Have Lower Malignant neoplasm progression Risk?
ATORVASTATIN vs ATORVASTATIN\EZETIMIBE
ATORVASTATIN vs ATOSIBAN
ATORVASTATIN vs ATOVAQUONE
ATORVASTATIN vs ATOVAQUONE\PROGUANIL
ATORVASTATIN vs ATRACURIUM